Copyright
©The Author(s) 2025.
World J Gastrointest Pathophysiol. Mar 22, 2025; 16(1): 101481
Published online Mar 22, 2025. doi: 10.4291/wjgp.v16.i1.101481
Published online Mar 22, 2025. doi: 10.4291/wjgp.v16.i1.101481
Table 2 Anti-TNFα induced autoimmune hepatitis
Ref. | Country | Age | Comorbidities | AIH type | Previous intervention | Intervention | Comparison | Type of the study | Outcome | Result |
Jenkins et al[31] | United States | 31 | UC | AIH induced by infliximab | Mesalamine, prednisone, adalimumab, Clostridioides difficile colitis | Suspension of Infliximab and use of Vedolizumab | None | Case report | AST and ALT improvement -AIH; Clinical and endoscopic improvement - UC | UC was controlled with the use of Vedolizumab AST and ALT normalized after infliximab was withdrawn |
Wong et al[32] | Canada | 69 | AIH, HTN, diverticular disease | AIH induced by infliximab | Prednisolone | Infliximab | No comparison | Case report | Elevated AST and ALT, with elevated INR and positive ASMA and ANA. Liver biopsy showed multiacinar hepatocyte necrosis and interface hepatitis | Infliximab led to deterioration in liver markers compared to baseline instead of improvement |
Mancini, et al[33] | Italy | 33 | Psoriasis | AIH induced by infliximab | Methotrexate | Infliximab and prednisone | No comparison | Case report | Elevated AST and ALT levels, positive ANA and anti-dsDNA | Infliximab induced AIH |
Adar et al[34] | Israel | 36 | Psoriasis and psoriatic arthritis, hypothyroidism, Crohn’s disease | AIH induced by adalimumab | AZA, methotrexate and prednisolone | Adalimumab | No comparison | Case report | Elevated AST and ALT and IgG levels, positive ANA and anti-DNA. Liver biopsy showed fibrosis, inflammatory cell infiltrate, interface hepatitis, and hepatic rosettes | Adalimumab induced AIH, which was discontinued due to adverse effects |
Karanfilian et al[35] | United States | 37 | Crohn’s disease, psoriasis | AIH induced by infliximab | Prednisone | Infliximab | No comparison | Case report | Elevated AST and ALT, positive ANA and weakly positive smooth muscle antibody Liver biopsy showed active hepatitis with moderate interface activity, cholestasis, and infiltrate of eosinophils and plasma cells | Severe drug-induced autoimmune hepatitis secondary to infliximab and discontinuation of infliximab led to improvement in liver function tests |
Rodrigues et al[36] | Portugal | 22-69 year (8 pts) | Ulcerative colitis, Ankylosing spondylitis, Psoriatic arthritis, Rheumatoid arthritis; Crohn’s disease, Palmoplantar pustular psoriasis | AIH induced by infliximab | Prednisone administered all AIH patients | Infliximab administered in 7 cases. Adalimumab administered in 1 case | No comparison | Case series | Infliximab: Six patients developed AIH and one patient developed DILI and cirrhosis | Normalisation of the liver function testes after discontinuation of anti-TNF |
Yilmaz et al[37] | United States | 39 | Ankylosing spondylitis | AIH induced by infliximab | Methotrexate, sulfasalazine, hydroxychloroquine | Infliximab | No comparison | Case report | ALT and AST elevated with positive ANA. Liver biopsy showed an acute autoimmune hepatitis with a lymph plasmatic infiltration | Normal liver function tests two months after discontinuation of the anti-TNF drug |
Dang et al[38] | Australia | 47 | Chronic plaque psoriasis | AIH induced by infliximab | Methotrexate | Infliximab | No comparison | Case report | Elevated AST, ALT and IgG levels. Liver biopsy indicated acute AIH | Infliximab discontinued and liver condition improved |
van Casteren-Messidoro et al[39] | Netherlands | 46 and 30 | Case 1: Crohn's disease, erythema nodosum Case 2: UC | AIH induced by infliximab | Prednisone and AZA | Case 1: Infliximab; Case 2: Pregnant, infliximab and azathioprine | No comparison | Case series | Case 1 After the fourth infliximab dose, positive ANA and IgG; liver biopsy indicated acute AIH Case 2: Elevated AST and ALT; liver biopsy showed hepatitis | In both cases liver enzymes improved after infliximab was withdrawn |
Cravo et al[40] | Portugal | 38 | Crohn’s disease | AIH induced by infliximab | Azathioprine and prednisolone | Infliximab and Adalimumab | Infliximab vs Adalimumab | Case report | AIH induced by Infliximab and switched to adalimumab. Elevated AST and ALT and IgG with positive ANA, anti-dsDNA, and antihistone antibodies. Liver Biopsy showed chronic hepatitis and mild periportal fibrosis | Infliximab discontinued and with adalimumab liver function normalized |
Grasland et al[41] | France | 35 | Hypertension, obesity | AIH induced by adalimumab | Methotrexate, prednisone, NSAIDs, paracetamol and etanercept | Adalimumab | Adalimumab vs Abatacept | case report | AIH induced by Adalimumab - AST and ALT elevated | Adalimumab was discontinued and liver function improved Abatacept was restarted and liver enzymes normalized |
Petríková et al[42] | Slovakia | 33 | Sjögren syndrome, rheumatoid arthritis | AIH induced by adalimumab | Etanercept, certolizumab and anakinra | Adalimumab | No comparison | Case report | Increased AST, ALT, IgG and positive ASMA and AMA. Liver biopsy showed chronic hepatitis suggestive of AIH | Adalimumab induced autoimmune hepatitis and liver enzymes improved with withdrawal of adalimumab |
- Citation: Eldew H, Soldera J. Evaluation of biological therapies in autoimmune hepatitis: A case-based systematic review. World J Gastrointest Pathophysiol 2025; 16(1): 101481
- URL: https://www.wjgnet.com/2150-5330/full/v16/i1/101481.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v16.i1.101481